Deciphera Pharmaceuticals Inc
DCPH - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.21B
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $2.21 Billion |
|---|---|
| Enterprise Value | $2.15 Billion |
| Earnings per Share | $-2.29 |
| Beta | 0.18 |
| Outstanding Shares | 87,388,106 |
Return
| Return on Equity | -60.25% |
|---|---|
| Return on Assets | -45.24% |
| Return on Invested Capital | -61.34% |
Valuation & Multiples
| P/E Ratio | -11.17 |
|---|---|
| PEG | 122.48 |
| Price to Sales | 12.8 |
| Price to Book Ratio | 8.53 |
| Enterprise Value to Revenue | 12.27 |
| Enterprise Value to EBIT | -10.37 |
| Enterprise Value to Net Income | -12 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.08 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Deciphera Pharmaceuticals Inc
CEO: Steven Hoerter
